Home›People›Elizabeth Bhatt
EB

Elizabeth Bhatt

President and COO at Septerna.

ExecutivePublic company
Updated Oct 27, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About Elizabeth Bhatt

Elizabeth Bhatt is a president and COO at Septerna.

Elizabeth Bhatt reports to the SEC as a director or officer of 4 public companies, including eFFECTOR Therapeutics (EFTR), Applied Molecular Transport (AMTI) and Achaogen (AKAO).

Elizabeth Bhatt first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Elizabeth Bhatt in the role, so the role may have started earlier or lasted longer.

Septerna, Inc.
President and COO
2023 – 2026 · Public company (SEPN)
eFFECTOR Therapeutics, Inc.
Director
2021 – 2024 · Public company (EFTR)
Applied Molecular Transport Inc.
Chief Bus. & Strategy Officer
2020 – 2022 · Public company (AMTI)
Achaogen, Inc.
Chief Operating Officer
2018 – 2019 · Public company (AKAO)

Key Colleagues at Startups

The people Elizabeth Bhatt works with at each company, as listed on that company's latest Form D.

Septerna, Inc. · Form D, Jul 13, 2023
AE
RX
Ran Xiao
Executive officer
JT
Jeffrey Tong
Director
JS
Jake Simson
Director
AB
JF
Jeffrey Finer
Chief Executive Officer and director
SS
Samira Shaikhly
Executive officer

Sources

  1. SECSepterna, Inc. Form D, filed Jul 13, 2023
  2. SECForms 3, 4 and 5 filed by Elizabeth Bhatt (SEC filer 1748622)